adagrasib,Pembrolizumab
mirati,merck
['nsclc', 'sclc', 'adagrasib', 'krystal-1', 'pembro', 'lung', 'krystal-7']
kras inhibitors plus io . adagrasib plus pembrolizumab for nscl. krystal -7 data . good activity. phase 3 trial will be intresting. #esmoimmuno22 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists